NeuroDerm Ltd.

14 clinical trials · Sponsor

Record	Firm	Date
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (NCT04006210)	NeuroDerm Ltd.	2019-09-30
A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension (NCT03462043)	NeuroDerm Ltd.	2018-04-10

Every clearance here is in the API, with alerts when new ones post.